Haemophilus parasuis colonizes in the upper respiratory tract of
pigs and is the causative agent of Glässer’s disease.[1] The typical characteristics of Glässer’s disease are polyserositis,
meningitis, and arthritis.[2] So far, at least 15 serovars of H. parasuis have been
identified using heat-stable Ag extracts,[3] but up to 20% of isolates cannot be serotyped. In China, serovars 4, 5, and
13 were thought to be the most frequently occurring.[4] In general, serovars are considered to be virulence markers of H.
parasuis.[5] Serovar 5 is thought to be highly virulent, resulting in high mortality, and
serovar 4 is considered to be moderately virulent in swine.[6] Because the pathogenic mechanism of H. parasuis infection is
not clear and there is a lack of cross-immunity protection between different
serovars, controlling the infection caused by H. parasuis has
become more difficult.Baicalin is the major bioactive compound extracted from the traditional Chinese
medicinal herb Baikal skullcap (Scutellaria baicalensis Georgi),
known as Huang qin.[7] It has been found that baicalin has important biological functions. Baicalin
reduces biofilm formation, attenuates the quorum sensing-controlled virulence, and
enhances clearance of Pseudomonas aeruginosa from mice.[8] Baicalin significantly improves the survival of mice with Escherichia
coli–induced sepsis and inhibits activation of NLRP3 inflammasome
through augmenting protein kinase (PK) A signaling.[9] It has also been shown that baicalin inhibits PKC and receptor for advanced
glycation end products (RAGE) expression in streptozotocin-induced diabeticrats.[10] Baicalin treatment reduces the high phosphorylation levels of c-Jun
N-terminal kinase (JNK), p65, p-38, and ERK1/2 triggered by atherosclerosis.[11] These studies suggest that baicalin acts as an anti-inflammatory regulator
and inhibits p38 MAPK signaling pathways in Glässer’s disease.In this study, we focused on activation of the MAPK signaling pathway in porcine
aortic vascular endothelial cells (PAVECs) during H. parasuisinfection and the inhibitory effect of baicalin on activation of the MAPK signaling
pathway induced by H. parasuis. Our results demonstrate that
H. parasuis could trigger the activation of MAPK signaling
pathway in PAVECs. Baicalin displayed inhibitory effects on activation of the MAPK
signaling pathway induced by H. parasuis, which may provide a new
target to control H. parasuis infection.
Materials and methods
Ethics approval
This study was performed in strict accordance with the recommendations of the
China Regulations for the Administration of Affairs Concerning Experimental
Animals 1988 and Hubei Regulations for the Administration of Affairs Concerning
Experimental Animals 2005. The protocols were approved by China Hubei Province
Science and Technology Department (permit number SYXK(ER) 2010-0029). All
experimental animals were euthanized at the end of the experiments. All
experiments were approved by Wuhan Polytechnic University guidelines and
regulations.
Bacterial strain, growth conditions, and drug
H. parasuis SH0165 strain, a highly virulent strain of serovar
5, was isolated from the lung of a commercial pig with arthritis, fibrinous
polyserositis, hemorrhagic pneumonia, and meningitis.[12,13] The SH0165 strain was
grown in tryptic soy broth (Difco Laboratories, Detroit, MI) or tryptic soy agar
(Difco Laboratories) supplemented with 10 μg/ml NAD (Sigma–Aldrich, St. Louis,
MO) and 10% newborn calf serum (Gibco, Gaithersburg, MD) at 37°C. Baicalin was
obtained from the National Institutes for Food and Drug Control (Beijing, P.R.
China; B110715-201318). Baicalin was dissolved and diluted in RPMI-1640 medium
(Gibco).
Isolation and culture of PAVECs
Ten 30-d-old naturally farrowed, early-weaned piglets (Duroc×Landrace×large
white) weighing 6–8 kg which were detected to be negative for Ab against
H. parasuis by INGEZIM Haemophilus 11.
H. parasuis. K1 (INGEZIM, Spain), were obtained from Wuhan
Jinying Livestock Co. Ltd. (Wuhan, P.R. China) and used for in
vitro experiments.PAVECs were isolated, cultured, and identified according to a previously
established method.[14] PAVECs were obtained in small sheets after treatment of the aortic lumen
(20 min at 37°C) with 0.1% type I collagenase (Sigma–Aldrich) in M-199 medium
(Gibco) containing penicillin-streptomycin solution (Gibco). The suspension was
centrifuged at 100 g for 10 min, and the cells from one aorta
were re-suspended in 5 ml M-199 containing 20% FBS (Gibco), and then plated in a
T-25 tissue-culture plate (Costar, Washington, DC). PAVECs were counted, and
their viability was determined by Trypan Blue exclusion. PAVECs were identified
by the uptake of acetylated low-density lipoprotein (Ac-LDL). PAVECs were
incubated with 10 μg/ml 1,1′-dioctadecyl-3,3,3′,3′-tetramethylindocarbocyanine
(DiI)-labeled Ac-LDL (Invitrogen, Carlsbad, CA) in medium for 12 h at 37°C. The
cells were washed three times with PBS, detached by trypsinization, and detected
by fluorescence microscopy.
Evaluation of expression of RAGE, apoptosis-related genes, and the
anti-apoptotic gene by RT-PCR
To explore the expression levels of RAGE, apoptosis-related genes
(Bax, C-myc, and Fasl),
and the anti-apoptotic gene (Bcl-xl) in the PAVECs infected
with H. parasuis, 2 × 107 cells were seeded onto
24-well plates and treated with baicalin at a concentration of 12.5, 25, 50, or
100 μg/ml for 1 h. N-Acetyl-L-cysteine (NAC; 1 mM/ml)
was added as a positive control. Afterwards, 2 × 107 CFU/ml
H. parasuis was added to the wells and co-cultured for 6 h.
The PAVECs were collected, and total RNA was extracted using TRIzol reagent
(Invitrogen). The RNA obtained was reverse transcribed to cDNA using reverse
transcriptase (TaKaRa, Dalian, P.R. China). cDNA amplification was carried out
by the SYBR Green PCR Kit (Applied Biosystems, Foster City, CA) using an ABI
7500 real-time PCR system (Applied Biosystems). Individual transcripts of each
sample were repeated three times and β-actin was used as the internal control.
Nucleotide sequences of the primers utilized for RT-PCR are listed in Table 1.
Table 1.
Primers for qRT-PCR.
Gene
Nucleotide sequence (5′-3′)
Temperature (°C)
Length (bp)
β-actin
Forward
TGCGGGACATCAAGGAGAAG
57.4
216
Reverse
AGTTGAAGGTGGTCTCGTGG
57.4
Bax
Forward
GCCGAAATGTTTGCTGACG
55.2
156
Reverse
GAGCCGATCTCGAAGGAAGT
57.4
Fasl
Forward
GCCAGCCAAAGGCATACAGAAT
57.7
335
Reverse
ATCTTTCCCTCCATCAGCACCA
57.7
Bcl-xl
Forward
GCAACCCATCCTGGCACCT
59.5
136
Reverse
TCAAACTCATCGCCCGCCT
57.3
C-myc
Forward
GGTCTTCCCCTACCCACT
57.2
200
Reverse
CCTCATCCTCTTGTTCTTCC
55.4
Rage
Forward
ATCCTGCCTCTGAACTCA
52.6
159
Reverse
GGTGTCTCCTGGTCTCTT
54.9
c-Fos
Forward
GCTGACAGATACACTCCAAGCGG
61.3
542
Reverse
AGGAAGACGTGTAAGTAGTGCAG
57.8
c-Jun
Forward
CGCCAGTCTACGCTAATC
55.1
288
Reverse
GGTTCCTCATACGCTTCC
54.8
Primers for qRT-PCR.
Western blotting
PAVECs (2 × 107) pre-treated with baicalin at a concentration of 12.5,
25, 50, or 100 μg/ml for 2 h were co-cultured with 2.0 × 107 CFU/ml
H. parasuis for 12 h. PAVECs proteins were extracted using
a total protein extraction kit (Beyotime Biotechnology, Shanghai, P.R. China).
Total proteins were isolated by 12% SDS-PAGE and transferred to polyvinylidene
difluoride (PVDF) membranes. The PVDF membranes were blocked with 5% skimmed
milk at 37°C for 2 h and washed five times with TBST. The PVDF membranes were
incubated with respective Ab, or anti-β-actin Ab (Cell Signaling Technology,
Danvers, MA) for 8 h at 4°C. The PVDF membranes were washed five times with TBST
and incubated with HRP-linked goat anti-rabbit Ab (Cell Signaling Technology) at
37°C for 2 h and visualized using enhanced chemiluminescence solution (Pierce;
Thermo Fisher Scientific, Waltham, MA). The levels of the proteins and β-actin
were examined using the FluorChemFC2 AIC system (Alpha Innotech, San Leandro,
CA).
Localization of c-Jun with indirect immunofluorescence
The subcellular localization of c-Jun was explored in the PAVECs. PAVECs
(2 × 107) were seeded onto 24-well plates and treated with
baicalin at a concentration of 12.5, 25, 50, or 100 μg/ml or NAC (1 mM/ml) for
2 h, and 2 × 107 CFU/ml H. parasuis were
co-incubated with the PAVECs for 12 h. The cells were fixed with 4%
paraformaldehyde for 1 h at 37°C and permeabilized with 0.1% Triton X-100 for
30 min. The PAVECs were incubated with anti-rabbit c-Jun (60A8) rabbit mAb (Cell
Signaling Technology) or Phospho-c-Jun (Ser73) (D47G9) XP® Rabbit mAb (Cell
Signaling Technology) for 1 h. PAVECs were incubated with Cy3-labeled goat
anti-rabbit IgG (H+L; Boster, Wuhan, P.R. China). 4′,6′-diamidino-2-phenylindole
(DAPI; 1 μg/ml; Beyotime) was co-cultured with the PAVECs for 30 min. The
subcellular localization of c-Jun and phosphor (p)-c-Jun was visualized using a
Nikon C2 confocal laser-scanning microscope (Nikon, Tokyo, Japan).
Cell-cycle analysis using flow cytometry
The effects of baicalin on the cell cycle of PAVECs infected by H.
parasuis were determined as described previously, with some modifications.[15] PAVECs (2 × 107) were seeded onto 24-well plates and treated
with baicalin at a concentration of 12.5, 25, 50, or 100 μg/ml for 2 h.
H. parasuis (2 × 107 CFU/ml) was added to the
plates and co-incubated for 12 h. Cells were washed five times with sterile PBS
and stained with PI/RNase Staining Buffer (BD, USA), and the cell cycle was
detected by flow cytometry (FC500; Beckman Coulter, USA).
Detection of the effect of baicalin on the interaction between PAVECs and
H. parasuis by transmission electron microscopy
The effect of baicalin on the interaction between PAVECs and H.
parasuis was examined by transmission electron microscopy (TEM) as
described previously, with minor modifications.[16] PAVECs (2 × 107) were seeded onto 24-well plates and treated
with baicalin at a concentration of 12.5, 25, 50, or 100 μg/ml for 2 h prior to
bacterial infection. H. parasuis (2 × 107 CFU/ml)
was added to the plates and co-incubated for 12 h. The infected cells were
gently washed five times with PBS. PAVECs were fixed with 0.1 M cacodylate
buffer (pH 7) including 5% glutaraldehyde and 0.15% ruthenium red at 37°C for
5 h. PAVECs were reacted with polycationic ferritin (1 mg/ml). The thin sections
were examined by a Tecnai G2 20 TWIN transmission electron microscope
(FEI, Hillsboro, OR).
Statistical analysis
The experimental data are expressed as the mean±SD. The
difference among two groups was analyzed using Student’s
t-test. P < 0.05 was considered
significant.
Results
Baicalin inhibited expression of RAGE in PAVECs triggered by H.
parasuis
To determine expression of RAGE, the PAVECs were infected with H.
parasuis for 6 h, and RAGE was detected by RT-PCR. H.
parasuis stimulated expression of RAGE compared to the control
cells (Figure 1). PAVECs
were treated with baicalin for 2 h, and mRNA was isolated. NAC significantly
suppressed RAGE expression in PAVECs infected with H. parasuis
(P < 0.01; Figure 1). Also, 12.5–100 μg/ml baicalin
decreased expression of RAGE mRNA in a dose-dependent manner
(P < 0.01; Figure 1).
Figure 1.
Effect of baicalin on expression of receptor for advanced glycation end
products in porcine aortic vascular endothelial cells (PAVECs) infected
with Haemophilus parasuis. HPS: H.
parasuis. ##P<0.01 versus
control; **P < 0.01.
Effect of baicalin on expression of receptor for advanced glycation end
products in porcine aortic vascular endothelial cells (PAVECs) infected
with Haemophilus parasuis. HPS: H.
parasuis. ##P<0.01 versus
control; **P < 0.01.
Baicalin suppressed H. parasuis-infected PAVECs PKC-α and
PKC-δ phosphorylation
Rage mediates activation of PKC-α and PKC-δ.[17] To determine whether PAVECs can respond to RAGE, PAVECs were examined for
PKC-α and PKC-δ phosphorylation in response to H. parasuis or
baicalin treatment. H. parasuis induced a significant increase
in phosphorylation of PKC-α and PKC-δ (P < 0.01; Figure 2b and d). Baicalin
treatment at 12.5–100 μg/ml significantly reversed phosphorylation of PKC-α and
PKC-δ of PAVECs in a dose-dependent manner (P < 0.05; Figure 2b and d).
Figure 2.
Effect of baicalin on phosphorylation of protein kinase (PKC)-α and PKC-δ
of PAVECs. (a) the ratio of PKC-α/β-actin; (b) the ratio of
p-PKC-α/β-actin; (c) the ratio of PKC-δ/β-actin; (d) the ratio of
p-PKC-δ/β-actin. ##P < 0.01 versus
control; *P < 0.05;
**P<0.01.
Effect of baicalin on phosphorylation of protein kinase (PKC)-α and PKC-δ
of PAVECs. (a) the ratio of PKC-α/β-actin; (b) the ratio of
p-PKC-α/β-actin; (c) the ratio of PKC-δ/β-actin; (d) the ratio of
p-PKC-δ/β-actin. ##P < 0.01 versus
control; *P < 0.05;
**P<0.01.
Effect of baicalin on phospho-ERK, -JNK, -p38, and total-ERK, -JNK, -p38
expression in PAVECs
The MAPK signaling pathway plays an important role in vascular damage.[18] Therefore, we examined the effect of H. parasuis on
activation of the MAPK signaling pathway in PAVECs. The PAVECs were infected
with H. parasuis, and phosphorylation of MAPK was measured
using phospho-specific Abs. H. parasuis significantly
up-regulated ERK, JNK, and p38 phosphorylation in PAVECs
(P < 0.01; Figure 3b, d and f). In contrast, ERK, JNK, and p38 phosphorylation
in PAVECs triggered by H. parasuis was suppressed by NAC
(P < 0.05; Figure 3b, d, and f). Baicalin treatment
at a concentration of 12.5–100 μg/ml reduced ERK, JNK, and p38 phosphorylation
in PAVECs induced by H. parasuis (P < 0.01)
in a dose-dependent manner (Figure 3b, d, and f).
Figure 3.
Effect of baicalin on phospho-ERK, -JNK, and -p38, and total-ERK, -JNK.
and -p38 expression in PAVECs by Western blotting. (a) the ratio of
Erk/β-actin; (b) the ratio of p-Erk/β-actin; (c) the ratio of
JNK/β-actin; (d) the ratio of p-JNK/β-actin; (e) the ratio of
p38/β-actin; (f) the ratio of p-p38/β-actin.
##P < 0.01 versus control;
*P < 0.05; **P < 0.01.
Effect of baicalin on phospho-ERK, -JNK, and -p38, and total-ERK, -JNK.
and -p38 expression in PAVECs by Western blotting. (a) the ratio of
Erk/β-actin; (b) the ratio of p-Erk/β-actin; (c) the ratio of
JNK/β-actin; (d) the ratio of p-JNK/β-actin; (e) the ratio of
p38/β-actin; (f) the ratio of p-p38/β-actin.
##P < 0.01 versus control;
*P < 0.05; **P < 0.01.
Effect of baicalin on expression of mitochondrial apoptosis-related genes in
PAVECs triggered by H. parasuis
Apoptosis is mediated by activation of the caspase cascades. To determine the
role of caspase-3 in H. parasuis-induced apoptosis in PAVECs,
we examined the level of activated caspase-3 using Western blotting. Higher
activity of cleaved caspase-3 in PAVECs was activated by H.
parasuis, and the activity of cleaved caspase-3 was significantly
inhibited by baicalin at a concentration of 12.5–100 μg/ml
(P < 0.01; Figure 4a). To study the molecular mechanism of
mitochondria-dependent apoptosis triggered by H. parasuis
further, we examined expression of apoptotic genes (Bax,
C-myc, and Fasl) and the anti-apoptotic
gene (Bcl-xl). H. parasuis up-regulated the
levels of apoptotic genes (Bax, C-myc, and
Fasl) compared to the controls, and baicalin at a
concentration of 25–100 μg/ml down-regulated the apoptotic genes
(Bax, C-myc, and, Fasl;
P < 0.05; Figure 4b, c, and d). H.
parasuis promoted expression of the anti-apoptotic gene
(Bcl-xl) compared to the controls
(P < 0.01; Figure 4e).
Figure 4.
Effect of baicalin on expression of mitochondrial apoptosis-related genes
in PAVECs triggered by H. parasuis. After PAVECs were
treated with baicalin and infected with H. parasuis,
expression of mitochondrial apoptosis-related genes
(Bax, C-myc,
Fasl, and Bcl-xl) and
apoptosis-related protein (cleaved caspase-3) was measured. β-Actin was
used as reference. (a) the ratio of caspase-3/β-actin; (b) the
expression of Bax at mRNA level; (c) the expression of C-myc at mRNA
level; (d) the expression of Fasl at mRNA level; (e) the expression of
Bcl-xl at mRNA level. ##P < 0.01 versus
control; *P < 0.05;
**P < 0.01.
Effect of baicalin on expression of mitochondrial apoptosis-related genes
in PAVECs triggered by H. parasuis. After PAVECs were
treated with baicalin and infected with H. parasuis,
expression of mitochondrial apoptosis-related genes
(Bax, C-myc,
Fasl, and Bcl-xl) and
apoptosis-related protein (cleaved caspase-3) was measured. β-Actin was
used as reference. (a) the ratio of caspase-3/β-actin; (b) the
expression of Bax at mRNA level; (c) the expression of C-myc at mRNA
level; (d) the expression of Fasl at mRNA level; (e) the expression of
Bcl-xl at mRNA level. ##P < 0.01 versus
control; *P < 0.05;
**P < 0.01.
Effect of baicalin on activation of transcription factor activator protein-1
in PAVECs induced by H. parasuis
After the PAVECs were stimulated by H. parasuis, the activator protein (AP)-1
transcription factors c-Jun and c-Fos were determined by RT-PCR. H.
parasuis significantly up-regulated expression of c-Jun and c-Fos
mRNA compared to the controls (P < 0.01; Figure 5a and b). We also
detected the subcellular localization of c-Jun in PAVECs triggered by H.
parasuis. Cytoplasmic-to-nuclear translocation of p-c-Jun was
detected in the H. parasuis-infected cells, while p-c-Jun was
rarely observed in the cytoplasm of NAC-treated cells (Figure 5d; P < 0.05).
A high level of production of p-c-Jun was observed in the nuclei of the cells
treated with 12.5 μg/ml baicalin. However, 25–100 μg/ml baicalin significantly
inhibited p-c-Jun production from the extracellular to the nuclei (Figure 5d;
P < 0.05).
Figure 5.
Effect of baicalin on expression of c-Jun and c-Fos in PAVECs triggered
by H. parasuis (a and b); and localization of c-Jun by
indirect immunofluorescence (c and d).
##P < 0.01 versus control;
**P < 0.01.
Effect of baicalin on expression of c-Jun and c-Fos in PAVECs triggered
by H. parasuis (a and b); and localization of c-Jun by
indirect immunofluorescence (c and d).
##P < 0.01 versus control;
**P < 0.01.
Effect of baicalin on the cell cycle in PAVECs triggered by H.
parasuis
PAVECs were infected by H. parasuis and stained with PI/RNase
Staining Buffer, and the cell cycle was measured by flow cytometry. H.
parasuis induced S-phase arrest in PAVECs stimulated by H.
parasuis compared to the control cells (Figure 6; P < 0.01).
We also evaluated the effect of baicalin on cell-cycle distribution in PAVECs.
The positive control, NAC, reduced S-phase arrest in the PAVECs (Figure 6;
P < 0.01). Baicalin at a concentration of 25–100 μg/ml
significantly reversed the S-phase arrest in PAVECs induced by H.
parasuis (Figure
6; P < 0.01).
Figure 6.
Effect of baicalin on cell cycle of PAVECs by flow cytometric analysis.
(a) control cells; (b) cells infected with H. parasuis;
(c–g) cells treated with NAC or baicalin; (h) the effect of baicalin on
the cell population of PAVECs. ##P < 0.01
versus control; **P < 0.01.
Effect of baicalin on cell cycle of PAVECs by flow cytometric analysis.
(a) control cells; (b) cells infected with H. parasuis;
(c–g) cells treated with NAC or baicalin; (h) the effect of baicalin on
the cell population of PAVECs. ##P < 0.01
versus control; **P < 0.01.
Effect of baicalin on interaction between PAVECs and H.
parasuis
TEM revealed morphological alterations in bacterium–cell interactions. There was
a direct interaction between H. parasuis and PAVECs, and
adhesion to or invasion of PAVECs elicited the morphological alterations (Figure 7c and d). Baicalin
at a concentration of 12.5–100 μg/ml improved morphological damage to PAVECs by
H. parasuis, although the bacteria were present in the
cells (Figure 7e, f, g, and
i) or adhension to the cells (Figure 7h). Lysosomes and mitochondria
increased significantly after PAVECs were treated with baicalin at a
concentration of 12.5–100 μg/ml (Figure 7e–i).
Figure 7.
Effect of baicalin on the interaction between PAVECs and H.
parasuis by transmission electron microscopy. (a)
H. parasuis (HPS). (b) PAVECs. (c and d) H.
parasuis adhesion to (c) or invasion of (d) PAVECs. (e–i)
PAVECs were treated with different concentrations of baicalin. Arrows
show the presence of bacteria.
Effect of baicalin on the interaction between PAVECs and H.
parasuis by transmission electron microscopy. (a)
H. parasuis (HPS). (b) PAVECs. (c and d) H.
parasuis adhesion to (c) or invasion of (d) PAVECs. (e–i)
PAVECs were treated with different concentrations of baicalin. Arrows
show the presence of bacteria.
Discussion
Previous research has shown that bacteria adhere to target cells as the first
essential event in infection.[19,20] If attachment is established,
the bacteria may utilize their potential to build a niche in order to be conducive
to replication, colonization, and survival.[21,22] Then the cell-cycle
alternation, apoptosis, could be observed in order to obtain persistent colonization
during infection process.[23] In the present study, we showed that H. parasuis adhered to
or invaded PAVECs, resulting in cell-cycle arrest, apoptosis, and MAPK signaling
pathway activation.RAGE belongs to the immunoglobulin superfamily of cell surface molecules and is
considered to be a membrane receptor.[24] It has been recorded that activation of RAGE has important effects on the
inflammation immune and microorganism infection process. Helicobacter
pylori stimulates expression of RAGE in gastric biopsy specimens, which
is thought to be related to cancer-mediated inflammation.[25] RAGE expression affects the antiviral immunity during paucigranulocytic
asthma in early-life infection with respiratory syncytial virus in mice.[26] RAGE deficiency impairs clearance of Staphylococcus aureus
in sepsis in mice.[27] In addition, RAGE activation alters inflammation and bacterial clearance in a
murine model of pneumonia caused by Acinetobacter baumannii.[28] In this study, we showed that H. parasuis activated
expression of RAGE in PAVECs and baicalin reduced RAGE expression, but the mechanism
of action of RAGE resulting in inflammation, and further study is needed to
determine how baicalin reduces RAGE expression.It has been reported that activation of inflammatory signaling pathways, including
ERK, JNK, and p38, induces secretion of cytokines.[29] We showed that H. parasuis activated the inflammatory
signaling molecules ERK, JNK, and p38 in PAVECs. Our previous work demonstrated that
H. parasuis stimulates the production of IL-6, IL-8, IL-10, and TNF-α.[14] These molecules may serve as anti-H. parasuis immune
factors.[12,30] We also showed that baicalin inhibited ERK, JNK, and p38
phosphorylation. It is suggested that baicalin activates the Th1-induced immune
response, which results in the promotion of bacterial clearance.[8] Baicalin attenuates the Th17 immune response and reduces silica-induced
inflammation and fibrosis.[31] Consistent with our previous study, baicalin also reduces the levels of
IL-1β, IL-8, and TNF-α in LPS-induced mesenchymal stem cells, and the inflammation
response in the mesenchymal stem cells through the MAPK/ERK pathway.[32] Baicalin treatment inhibits acetaminophen-induced liver inflammation through
down-regulating the ERK signaling pathway.[33] These data suggest that baicalin regulates the inflammatory immune response
to resist infection and improve treatment.Endothelial cells are important components of blood vessels. It has been documented
that endothelial cells play important roles in regulating inflammation during the
inflammatory immune response to bacteria.[34] So, we hypothesized that endothelial cells might be key effectors of the
inflammatory immune response to bacteria that results in vascular damage during
infection. However, PAVECs have not been considered to have important regulatory
effects on the inflammatory immune response. Details are limited about how PAVECs
are regulated during the inflammatory immune response to H.
parasuis and what the functions of cell death are in this process. Our
previous studies showed that baicalin could inhibit the activation of NF-κB and
NLRP3 inflammasome signaling in PAVECs and piglet monocytes induced by H.
parasuis.[12,14] Baicalin could also attenuate the activation of PKC-MAPK
signaling pathways in piglet monocytes triggered by H. parasuis.[35] However, whether baicalin could modulate apoptosis via RAGE, MAPK, and AP-1
in PAVECs during H. parasuis invasion has not been investigated.
Previous research found apoptosis in monocytes during Streptococcus
pneumoniae infection,[36] macrophages infected with Mycobacterium bovis[37,38] or
Neisseria gonorrhoeae,[39] and HeLa cellsinfected by E. coli.[40] Whether PAVECs undergo apoptosis during H. parasuisinfection remains unclear. Therefore, we explored whether there was an interaction
between PAVECs and H. parasuis during cell death. We showed that
cleaved caspase-3 in PAVECs was activated during H. parasuisinfection. We further investigated the expression level of the apoptotic genes
Bax, C-myc, and Fasl and
found that it was up-regulated. The level of the anti-apoptotic gene
Bcl-xl was also up-regulated, although the mechanism needs
further investigation in our next study.In the present study, we demonstrated that H. parasuis infection of
PAVECs led to alteration of the cell cycle. SH0165, an isolated strain, was used to
infect PAVECs. The primary cells were used based on its significant relevance to the
monic environment of natural infection of H. parasuis.[14] Previous research has shown that bacterial infection can result in cell-cycle
modulation, which may be related to pathogenesis.[41]
Legionella pneumophila challenge of Hela cells in the S phase
induces Icm/Dot-dependent cell-cycle arrest.[42]
Mycobacterium tuberculosis can modulate the immune system through
altering host cell-cycle arrest at the G1/S transition to promote long-term
persistent infection.[43]
Neisseria meningitidis can cause G1 cell-cycle arrest in human
epithelial cells and Detroit 562 and NP69 cells.[44] To our knowledge, the present study is the first report that H.
parasuis interferes with cell-cycle regulation in PAVECs.In conclusion, these findings suggested that H. parasuis induces
MAPK signaling pathway activation and baicalin inhibits the MAPK signaling pathway
via regulation of the inflammatory immune response. Our study may provide a
potential host defense mechanism against H. parasuis, and baicalin
could be a therapeutic option in the management of H. parasuisinfection.
Authors: Jaisy Arikkatt; Md Ashik Ullah; Kirsty Renfree Short; Vivan Zhang; Wan Jun Gan; Zhixuan Loh; Rhiannon B Werder; Jennifer Simpson; Peter D Sly; Stuart B Mazzone; Kirsten M Spann; Manuel Ar Ferreira; John W Upham; Maria B Sukkar; Simon Phipps Journal: Elife Date: 2017-01-18 Impact factor: 8.140
Authors: Shulin Fu; Lei Xu; Sali Li; Yinsheng Qiu; Yu Liu; Zhongyuan Wu; Chun Ye; Yongqing Hou; Chien-An Andy Hu Journal: Vet Res Date: 2016-08-08 Impact factor: 3.683
Authors: Pankaj Deo; Seong H Chow; Iain D Hay; Oded Kleifeld; Adam Costin; Kirstin D Elgass; Jhih-Hang Jiang; Georg Ramm; Kipros Gabriel; Gordon Dougan; Trevor Lithgow; Eva Heinz; Thomas Naderer Journal: PLoS Pathog Date: 2018-03-30 Impact factor: 6.823